Assessment of the Dose Reduction and Discontinuation Associated With Anti-Fibrotic Medications in Patients With Idiopathic Pulmonary Fibrosis First published 10/11/2026 Last updated 10/11/2026 EU PAS number:EUPAS1000001179 Study Finalised